Duality Advisers LP Purchases New Position in Chemed Co. (NYSE:CHE)

Duality Advisers LP acquired a new position in Chemed Co. (NYSE:CHE) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 3,337 shares of the company’s stock, valued at approximately $1,505,000.

Other institutional investors have also recently bought and sold shares of the company. Harvest Fund Management Co. Ltd lifted its stake in shares of Chemed by 28.0% in the 1st quarter. Harvest Fund Management Co. Ltd now owns 462 shares of the company’s stock valued at $200,000 after purchasing an additional 101 shares during the period. MML Investors Services LLC boosted its holdings in shares of Chemed by 22.2% during the 1st quarter. MML Investors Services LLC now owns 1,077 shares of the company’s stock valued at $467,000 after buying an additional 196 shares in the last quarter. Tower Research Capital LLC TRC grew its position in shares of Chemed by 348.3% in the 1st quarter. Tower Research Capital LLC TRC now owns 130 shares of the company’s stock worth $57,000 after buying an additional 101 shares during the period. AXA increased its stake in shares of Chemed by 41.0% in the 1st quarter. AXA now owns 11,000 shares of the company’s stock worth $4,765,000 after acquiring an additional 3,200 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in shares of Chemed by 14.7% in the 1st quarter. Franklin Resources Inc. now owns 11,039 shares of the company’s stock worth $4,782,000 after acquiring an additional 1,413 shares in the last quarter. 88.73% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Donald E. Saunders sold 300 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $475.53, for a total transaction of $142,659.00. Following the transaction, the director now directly owns 6,736 shares of the company’s stock, valued at $3,203,170.08. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Patrick P. Grace sold 1,520 shares of the stock in a transaction on Thursday, June 18th. The shares were sold at an average price of $450.18, for a total value of $684,273.60. Following the sale, the director now directly owns 4,399 shares in the company, valued at $1,980,341.82. The disclosure for this sale can be found here. Insiders have sold 16,020 shares of company stock valued at $7,212,353 in the last three months. 3.96% of the stock is owned by insiders.

Separately, Zacks Investment Research raised shares of Chemed from a “hold” rating to a “buy” rating and set a $489.00 target price for the company in a research note on Tuesday, May 19th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $509.80.

CHE opened at $492.19 on Friday. The stock has a 50-day moving average price of $462.10 and a 200-day moving average price of $451.92. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.59 and a quick ratio of 0.78. The firm has a market cap of $7.81 billion, a PE ratio of 30.94, a P/E/G ratio of 3.07 and a beta of 0.70. Chemed Co. has a 1 year low of $330.01 and a 1 year high of $513.75.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, July 29th. The company reported $4.41 earnings per share for the quarter, beating analysts’ consensus estimates of $3.75 by $0.66. The business had revenue of $502.20 million during the quarter, compared to analyst estimates of $522.90 million. Chemed had a net margin of 12.99% and a return on equity of 36.71%. Chemed’s revenue was up 6.0% compared to the same quarter last year. During the same period last year, the business earned $3.36 EPS. As a group, sell-side analysts anticipate that Chemed Co. will post 15.98 EPS for the current year.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Featured Article: Earnings Per Share

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.